Achieve Response with the Power and Stability of the FVIII/vWF Complex*


  • Is indicated for the treatment of classical hemophilia A
  • Demonstrates a mean biologic half-life of 16.12 hours
  • Contains naturally occuring von Willebrand Factor (vWF)*
  • Is effective in a single dose**
Tell your healthcare provider about any side effect that bothers you or does not go away. Call your healthcare provider right away if bleeding is not controlled after using Koate-DVI. 

*Koate-DVI has not been investigated for efficacy in the treatment of von Willebrand disease, and hence is not approved for such usage
**A total of 306 bleeding episodes were treated in one study, of which 82% were treated adequately with a single infusion of Koate-DVI.


References: 1. Koate-DVI [prescribing information]. Fort Lee, NJ: Kedrion Biopharma Inc., 2012. 2. Powell JS, Bush M, Harrison J, Abildgaard C, Vosburgh E, Thompson AR, Hurst D. Safety and efficacy of solvent/detergent- treated antihaemophilic factor with an added 80 degrees C terminal dry heat treatment in patients with haemophilia A. Haemophilia. 2000;6(3):140-9.